An existing drug may block metastases in colorectal cancer
The development of this patent has been possible thanks to the study carried out by UCAM and the IMIB to find new drugs that act by reducing the migration and invasion of tumour cells
Supercomputing to research cellular rejuvenation and environment
The groups BIO-HPC and UKEIM of the UCAM obtain two new projects co-financed by the Séneca Foundation.
Murcian researchers achieve important advances in the fight against arthritis, alzheimer and diabetes
The ‘Nature Chemical Biology’ magazine, from the prestigious group Nature, published recently the results from the researchers from the Murcian Institution of Biosanitary Research of Arrixaca in collaboration with scientists from UCAM and the Hospital Clinic-IDIPBAS, that have discovered the action mechanism of the anti-inflammatory molecule that allows to develop new treatments against arthritis, alzheimer and diabetes